Children Less Susceptible to SARS-CoV-2 but More Infectious
MONDAY, Jan. 25, 2021 -- Children and adolescents are less susceptible to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, but are more infectious than older adults within households, according to a study published online Jan.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 25, 2021 Category: Pharmaceuticals Source Type: news

Merck discontinues development of SARS-CoV-2/COVID-19 vaccine candidates; continues development of two investigational therapeutic candidates
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the company is discontinuing development of its SARS-CoV-2/COVID-19 vaccine candidates, V590 and V591, and plans to focus its SARS-CoV-2/COVID-19 research strategy and production capabilities on advancing two therapeutic candidates, MK-4482 and MK-7110. (Source: World Pharma News)
Source: World Pharma News - January 25, 2021 Category: Pharmaceuticals Tags: Featured Merck Business and Industry Source Type: news

Hand sanitizer-induced ocular injury: a Covid-19 hazard in children - Yangzes S, Grewal S, Gailson T, Grewal SPS.
Hand hygiene is central to the prevention of transmission of severe acute respiratory syndrome coronavirus 2. The current literature illustrates the potential threat to skin and mucosal surfaces, especially the eyes, with use of alcohol-based hand rubs (AB... (Source: SafetyLit)
Source: SafetyLit - January 25, 2021 Category: International Medicine & Public Health Tags: Age: Infants and Children Source Type: news

Does herbal therapy for COVID-19 have implications for forensic practice? - Byard RW, Musgrave IF.
SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) is a coronavirus that causes COVID-19 (coronavirus disease 2019). First identified in China in December 2019 it has subsequently been responsible for a pandemic. The rapid spread of the disease w... (Source: SafetyLit)
Source: SafetyLit - January 25, 2021 Category: International Medicine & Public Health Tags: Home and Consumer Product Safety Source Type: news

Africa: Seven Things to Know About Covid-19 Variants in Africa
[WHO] Brazzaville -- New COVID-19 variants have emerged in Africa as the continent records a new peak in infections. While virus mutations are not unusual, those that are more infectious are worrisome. Professor Francisca Mutapi, Professor in Global Health Infection and Immunity, University of Edinburgh, explains the implications of SARS-CoV-2 variants and what African countries can do to respond. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - January 23, 2021 Category: African Health Source Type: news

Bamlanivimab + Etesevimab Reduces SARS - CoV - 2 Viral Load
No significant reduction seen in viral load at day 11 with bamlanivimab monotherapy in mild - to - moderate COVID - 19 (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - January 22, 2021 Category: Respiratory Medicine Tags: Family Medicine, Infections, Nursing, Pathology, Pharmacy, Pulmonology, Journal, Source Type: news

COVID-19 and mental health, Lancet Psychiatry
While the effects of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on the nervous system remain unclear, there is no doubt that the COVID-19 pandemic is bad for mental health. To alleviate the impact of both the virus and the measures taken to control its spread, we need high quality information about their immediate and long-term effects, and which countermeasures are most effective. The good news is that by October, 2020, mental health was top of the charts in terms of published papers and preprints on the effects of COVID-19. The bad news is that the quantity of papers is not matched by quality. In March,...
Source: Current Awareness Service for Health (CASH) - January 22, 2021 Category: Consumer Health News Source Type: news

Bamlanivimab + Etesevimab Reduces SARS-CoV-2 Viral Load
FRIDAY, Jan. 22, 2021 -- Treatment with bamlanivimab and etesevimab, but not monotherapy with bamlanivimab, is associated with a reduction in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral load in patients with mild-to-moderate... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 22, 2021 Category: Pharmaceuticals Source Type: news

New SARS-CoV-2 Variant Could Evade Antibodies
A preprint casts doubt on vaccine effectiveness in light of certain mutations in the 501Y.V2 variant that emerged from South Africa. (Source: The Scientist)
Source: The Scientist - January 22, 2021 Category: Science Tags: News & Opinion Source Type: news

South Africa: South African Scientists Who Discovered New Covid-19 Variant Share What They Know
[The Conversation Africa] Late last year the Network for Genomic Surveillance in South Africa (NGS-SA) led by the KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP) identified a rapidly spreading new variant of SARS-CoV-2, the virus that causes COVID-19. The new variant, called 501Y.V2, raises critical questions - including whether current vaccines and treatments will still be effective. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - January 22, 2021 Category: African Health Source Type: news

Mike Pompeo calls for investigation into Wuhan lab, but Biden likely won't hold the CCP accountable for bioweapon release
(Natural News) Former Secretary of State, Mike Pompeo, recently revealed new evidence that the Wuhan Institute of Virology (WIV) was the point of origin for SARS-CoV-2. Pompeo has called for an international investigation into the laboratory, yet China refuses to let anyone investigate the lab. In the fall of 2019, several laboratory workers from the... (Source: NaturalNews.com)
Source: NaturalNews.com - January 22, 2021 Category: Consumer Health News Source Type: news

COVID-19 and healthcare workers: a rapid systematic review into risks and preventive measures, BMJ Open
Objective The COVID-19 pandemic is demanding for occupational medicine and for public health. As healthcare workers (HCWs) fight impacts of SARS-CoV-2 on front lines, we must create safe work environments through comprehensive risk assessments, evaluation and effective implementation of counter-measures. We ask:'What does current literature report on health risks at workplaces regarding COVID-19?'and'What do current studies report on the effectiveness of enacted preventative recommendations?'(Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - January 22, 2021 Category: Consumer Health News Source Type: news

Declines in SARS-CoV-2 Transmission After Mitigation Measures Declines in SARS-CoV-2 Transmission After Mitigation Measures
The findings in this report confirm that state-mandated community mitigation efforts and routine public health interventions are effective in reducing new COVID-19 cases, hospitalizations, and deaths.Morbidity & Mortality Weekly Report (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 22, 2021 Category: Consumer Health News Tags: Public Health & Prevention Journal Article Source Type: news

What We Know and Don't Know About Virus Variants and Vaccines What We Know and Don't Know About Virus Variants and Vaccines
Leaders in infectious disease medicine address concerns about SARS-CoV-2 variants emerging in the US and globally, and assess the evidence.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - January 22, 2021 Category: Drugs & Pharmacology Tags: Infectious Diseases News Source Type: news

Rhesus macaques develop promising immune response to SARS-CoV-2
(University of California - Davis) In a promising result for the success of vaccines against COVID-19, rhesus macaque monkeys infected with the human coronavirus SARS-CoV-2 developed protective immune responses that might be reproduced with a vaccine. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - January 22, 2021 Category: Biology Source Type: news

NSAIDs might exacerbate or suppress COVID-19 depending on timing, mouse study suggests
(American Society for Microbiology) New research shows that non-steroidal anti-inflammatory drugs (NSAIDs) reduced both antibody and inflammatory responses to SARS-CoV-2 infection in mice. The study appears this week in the Journal of Virology, a publication of the American Society for Microbiology. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - January 22, 2021 Category: Infectious Diseases Source Type: news

SARS-CoV-2 infection in children, their parents in southwest Germany
(JAMA Network) In this observational study, the spread of SARS-CoV-2 infection during a period of lockdown in southwest Germany was particularly low in children ages 1 to 10 years old.   Overall, this large SARS-CoV-2 prevalence study in children is instructive for how ad hoc   mass testing provides the basis for rational political decision-making in a pandemic setting. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - January 22, 2021 Category: Infectious Diseases Source Type: news

Why Patterns In Covid-19 Variation Might Resemble Seasonal Flu
Waves of influenza, like cold-causing coronaviruses, don ’t come and go at random. They’re seasonal, recurring in patterns we can anticipate and plan ahead for. Will this be true of SARS-CoV-2? (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - January 21, 2021 Category: Pharmaceuticals Authors: William A. Haseltine, Contributor Tags: Healthcare /healthcare Innovation /innovation Coronavirus business pharma & Source Type: news

Monoclonal Antibody Combo Treatment Reduces Viral Load in COVID Monoclonal Antibody Combo Treatment Reduces Viral Load in COVID
Bamlanivimab and etesevimab together were associated with a statistically significant reduction in SARS-CoV-2. Bamlanivimab alone, however, showed no significant reduction in a phase 2/3 study.Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - January 21, 2021 Category: Internal Medicine Tags: Infectious Diseases News Source Type: news

Emergence of SARS-CoV-2 B.1.1.7 Lineage - United States, December 29, 2020-January 12, 2021
This report describes SARS-CoV-2 variants of concern, including the B.1.1.7 variant, and modeling data indicating that B.1.1.7 has the potential to increase the U.S. pandemic trajectory in the coming months. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - January 21, 2021 Category: American Health Tags: Coronavirus [CoV] MMWR Morbidity & Mortality Weekly Report COVID-19 Coronavirus Disease 2019 Source Type: news

Evaluation of Abbott BinaxNOW Rapid Antigen Test for SARS-CoV-2 Infection at Two Community-Based Testing Sites - Pima County, Arizona, November 3-17, 2020
This report describes the performance of the BinaxNOW rapid antigen test on specimens collected from persons at two community testing sites in Pima County, Arizona. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - January 21, 2021 Category: American Health Tags: Coronavirus [CoV] MMWR Morbidity & Mortality Weekly Report SARS (Severe acute respiratory syndrome) COVID-19 Coronavirus Disease 2019 Source Type: news

For Insight On New Covid-19 Variants, Look To Natural History Of Coronaviruses
Though the human coronavirus 229E isn ’t nearly as hot a topic as SARS-CoV-2 these days, it is one of several coronaviruses that have been causing us colds for more than half a century. It also has lessons to teach us about the ability of coronaviruses to evolve and evade immunity over time. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - January 21, 2021 Category: Pharmaceuticals Authors: William A. Haseltine, Contributor Tags: Healthcare /healthcare Innovation /innovation business pharma & Source Type: news

COVID-19 - guidance for management of children admitted to hospital, RCPCH (updated 19th January 2021)
This best practice advice is focused on the management of confirmed or suspected SARS-CoV-2 infection in children admitted to hospital. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - January 21, 2021 Category: Consumer Health News Source Type: news

COVID-19 virus helps block host immunity
(Mary Ann Liebert, Inc./Genetic Engineering News) SARS-CoV-2, the virus that causes COVID-19, blocks the processes of innate immune activation that normally direct the production and/or signaling of type I interferon (IFN-I) by the infected cell and tissues. IFN-I is a key component of host innate immunity that is responsible for eliminating the virus at the early stage of infection (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 21, 2021 Category: International Medicine & Public Health Source Type: news

A closer look at T cells reveals big differences in mild vs. severe COVID-19 cases
(La Jolla Institute for Immunology) A big question on people's minds these days: how long does immunity to SARS-CoV-2 last following infection? Now a research team from La Jolla Institute for Immunology (LJI), The University of Liverpool and the University of Southampton has uncovered an interesting clue. Their new study suggests that people with severe COVID-19 cases may be left with more of the protective 'memory' T cells needed to fight reinfection. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - January 21, 2021 Category: Biology Source Type: news

New biochemical clues in cell receptors help explain how SARS-CoV-2 may hijack human cells
(American Association for the Advancement of Science) The SARS-CoV-2 virus may enter and replicate in human cells by exploiting newly-identified sequences within cell receptors, according to work from two teams of scientists. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - January 21, 2021 Category: Infectious Diseases Source Type: news

Effect of bamlanivimab as monotherapy or in combination with etesevimab on viral load in patients with mild to moderate COVID-19
(JAMA Network) This randomized clinical trial compares the effects of three doses of bamlanivimab monotherapy (700 vs 2,800 vs 7,000 mg) vs combination bamlanivimab and etesevimab vs placebo on change in day 11 severe acute respiratory syndrome coronavirus 2 viral load in patients with mild to moderate COVID-19. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - January 21, 2021 Category: Infectious Diseases Source Type: news

Presence of SARS-CoV-2 RNA in cornea of patients with COVID-19
(JAMA Network) Evidence of SARS-CoV-2 RNA in human corneas was examined in this study. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - January 21, 2021 Category: Infectious Diseases Source Type: news

What's the concern with COVID-19 variants?
Currently, three new variants of the virus (SARS-CoV-2) that causes coronavirus disease 2019 (COVID-19) are creating concern. They include: A variant identified in the U.K. This COVID-19 variant (B.1.1.7) has 23 mutations. Several of these mutations are in the spikelike S protein that the virus uses to attach itself to the surface of human cells. Early research suggests [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - January 21, 2021 Category: Databases & Libraries Source Type: news

BinaxNOW Rapid Antigen Test Has Lower Sensitivity Than RT-PCR
WEDNESDAY, Jan. 20, 2021 -- The Abbott BinaxNOW COVID-19 Ag Card (BinaxNOW) rapid antigen test has lower sensitivity than reverse transcription-polymerase chain reaction (RT-PCR) for detecting severe acute respiratory syndrome coronavirus 2... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 20, 2021 Category: Pharmaceuticals Source Type: news

COVID-19's Effects on the Brain
Autopsy studies have yet to find clear evidence of destructive viral invasion into patients' brains, pushing researchers to consider alternative explanations of how SARS-CoV-2 causes neurological... (Source: The Scientist)
Source: The Scientist - January 20, 2021 Category: Science Tags: News & Opinion Source Type: news

Men More Likely to Test Positive for SARS-CoV-2, Die From COVID-19
WEDNESDAY, Jan. 20, 2021 -- Men are more likely to test positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and to have complications of COVID-19, according to a study published online Jan. 13 in PLOS ONE. Farhaan S. Vahidy,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 20, 2021 Category: Pharmaceuticals Source Type: news

AHA News: COVID-19 Registries Offer Lessons Beyond the Coronavirus
WEDNESDAY, Jan. 20, 2021 (American Heart Association News) -- As the U.S. marks one year since the arrival of SARS-CoV-2, the coronavirus has made history in epic and terrible ways. But it also sparked innovative and inspiring science, say... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 20, 2021 Category: General Medicine Source Type: news

Covid-19: What new variants are emerging and how are they being investigated?, BMJ
Viewpoint discusses the more transmissible variant of SARS-CoV-2 found in England as well as the new variants emerging from Brazil and South Africa, whether the current vaccines work against these variants; and how the UK is monitoring and studying the new variants. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - January 20, 2021 Category: Consumer Health News Source Type: news

Here ’s What Joe Biden Can Do About the COVID-19 Pandemic Starting On His First Day as U.S. President
Every pandemic starts as a squall—a localized disturbance in a single city or town, causing all manner of problems there, but sparing the larger world outside. Squalls become storms, however, and storms become tempests and before long the entire world is being lashed by winds of disease and death that no one saw coming just a few months before. As President Joe Biden takes office, he is facing nothing short of a pathogenic typhoon, with COVID-19 raging around the world, nowhere more so than in the U.S., with some 24 million cases and 400,000 deaths—more than 20% of the global toll. If the pandemic unfolded in ...
Source: TIME: Health - January 20, 2021 Category: Consumer Health News Authors: Jeffrey Kluger Tags: Uncategorized COVID-19 Source Type: news

Covid new strain symptoms: Dr Chris warns of photophobia - the signs to spot
CORONAVIRUS mutations have added to the number of symptoms a person may experience if coming in contact with the SARS-CoV-2 virus. Dr Chris Steele warns of photophobia - what are the symptoms? (Source: Daily Express - Health)
Source: Daily Express - Health - January 20, 2021 Category: Consumer Health News Source Type: news

Pfizer and BioNTech publish results of study showing COVID-19 vaccine elicits antibodies that neutralize pseudovirus bearing the SARS-CoV-2 U.K. strain spike protein
Today, Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced results from an in vitro study that provides additional data on the capability of sera from individuals immunized with the Pfizer-BioNTech COVID-19 vaccine BNT162b2 to neutralize the SARS-CoV-2 U.K. strain, also known as B.1.1.7 lineage or VOC 202012/01. The results were published on the preprint server bioRxiv and submitted to a peer-reviewed journal. (Source: World Pharma News)
Source: World Pharma News - January 20, 2021 Category: Pharmaceuticals Tags: Featured Business Business and Industry Source Type: news

Southern Africa: Covid-19 Policy Briefs Must Be Realistic - a Review By Young Scientists
[The Conversation Africa] Just over a year after the coronavirus was first reported in China countries are still reeling from its effects. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19 disease, has infected over 90 million people globally and resulted in more than 1.9 million deaths. In January 2021, South Africa has the highest number of cases on the African continent and has seen a surge in daily infections since December. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - January 20, 2021 Category: African Health Source Type: news

Associations of government-mandated closures, restrictions with mobility, SARS-CoV-2 infections in Nigeria
(JAMA Network) This observational study examined how   COVID-19-related government-mandated closures and restrictions were associated with changes in mobility and the spread of COVID-19 in Nigeria. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - January 20, 2021 Category: Infectious Diseases Source Type: news

COVID-19 model reveals key role for innate immunity in controlling viral load
(American Chemical Society) Since SARS-CoV-2 was identified in December 2019, researchers have worked feverishly to study the novel coronavirus. Although much knowledge has been gained, scientists still have a lot to learn about how SARS-CoV-2 interacts with the human body, and how the immune system fights it. Now, researchers reporting inACS Pharmacology& Translational Science have developed a mathematical model of SARS-CoV-2 infection that reveals a key role for the innate immune system in controlling viral load. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - January 20, 2021 Category: Infectious Diseases Source Type: news

Genome sequencing of coronavirus in sewage can help detect local variants: Study
According to the research, published in the peer-reviewed journal mBio, the ability to track SARS-CoV-2 mutations in wastewater could be particularly useful for tracking new variants like the B.1.17 strain which is now widespread in the UK and has already been introduced in several countries, including India. (Source: The Economic Times)
Source: The Economic Times - January 20, 2021 Category: Consumer Health News Source Type: news

Coronavirus Variant Linked to COVID-19 Outbreaks in California
It's too early to know whether the L452R version of SARS-CoV-2 is highly infectious like the B.1.1.7 UK variant that is also spreading around the US. (Source: The Scientist)
Source: The Scientist - January 19, 2021 Category: Science Tags: News & Opinion Source Type: news

IgG Level in Convalescent Plasma Affects COVID-19 Death Risk
TUESDAY, Jan. 19, 2021 -- For patients hospitalized with COVID-19 and not receiving mechanical ventilation, the risk for death is reduced with transfusion of plasma with higher versus lower levels of anti-severe acute respiratory syndrome... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 19, 2021 Category: Pharmaceuticals Source Type: news

Here ’s How Scientists Are Using Sewage Water To Control Covid-19
Viral genome sequencing of wastewater can detect new SARS-CoV-2 variants before they are detected by local clinical sequencing, according to a new study. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - January 19, 2021 Category: Pharmaceuticals Authors: Misha Gajewski, Contributor Tags: Healthcare /healthcare Innovation /innovation Science /science Editors' Pick editors-pick Coronavirus Source Type: news

Nothing to Learn from East Asia?
By Jomo Kwame SundaramKUALA LUMPUR, Malaysia, Jan 19 2021 (IPS) Covid-19 infection and death rates in the Western world and many developing countries in Asia and Latin America have long overtaken East Asia since the second quarter of 2020. Perhaps unsurprisingly, considering prevailing Western accounts of the Asian financial crises, there have been no serious efforts to draw policy lessons from East Asian contagion containment. Jomo Kwame SundaramLockdowns necessary? Although most East Asian economies have successfully contained the pandemic without nationwide ‘stay in shelter lockdowns’, many governments have...
Source: IPS Inter Press Service - Health - January 19, 2021 Category: International Medicine & Public Health Authors: Jomo Kwame Sundaram Tags: Asia-Pacific Economy & Trade Financial Crisis Headlines Health Humanitarian Emergencies Labour TerraViva United Nations Source Type: news

South Africa: Higher Education Dept Puts U.S.$4.7 Million Into Covid-19 Research, Vaccine Development
[Daily Maverick] The Department of Higher Education has invested more than R68m into Covid-19 research and vaccine development. A further R25m has been allocated to the KwaZulu-Natal Research Innovation and Sequencing Platform (Krisp) to combat SARS-CoV-2 variants. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - January 19, 2021 Category: African Health Source Type: news

COVID-19 has multiple faces
According to current studies, the COVID-19 disease which is caused by the SARS-CoV-2 coronavirus comprises at least five different variants. These differ in how the immune system responds to the infection. Researchers from the German Center for Neurodegenerative Diseases (DZNE) and the University of Bonn, together with other experts from Germany, Greece and the Netherlands, present these findings in the scientific journal "Genome Medicine". (Source: World Pharma News)
Source: World Pharma News - January 19, 2021 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Update on Neurological Manifestations of SARS-CoV-2 Update on Neurological Manifestations of SARS-CoV-2
Are you aware of the neurological symptoms associated with the SARS-CoV-2 virus? This review provides an update.Western Journal of Emergency Medicine: Integrating Emergency Care with Population Health (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 19, 2021 Category: Consumer Health News Tags: Emergency Medicine Journal Article Source Type: news

Prevalence of SARS-CoV-2, Verona, Italy, April-May 2020 Prevalence of SARS-CoV-2, Verona, Italy, April-May 2020
A study of the prevalence of SARS-CoV-2 in Italy during the first few months of the pandemic sheds light on the circulation of the disease in the region.Emerging Infectious Diseases (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 19, 2021 Category: Consumer Health News Tags: Infectious Diseases Journal Article Source Type: news

Covid-19: how do you tweak a vaccine?
The emergence of more infectious variants of Sars-CoV-2 has raised questions about just how long our vaccines will remain effective for. Although there is little evidence that the current vaccines won ’t work against the new variants, as the virus continues to mutate scientists are preparing themselves for having to make changes to the vaccines in response. Speaking to Dr Katrina Pollock, science correspondentLinda Geddes asks how we can tweak the vaccines against new variants, and how likely it is we ’ll end up in a game of cat and mouse with the virusContinue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - January 19, 2021 Category: Science Authors: Presented by Linda Geddes and produced by Madeleine Finlay Tags: Science Coronavirus Infectious diseases Medical research Microbiology Vaccines and immunisation Health Source Type: news